相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Aniline-Substituted Bile Salt Analog Protects both Mice and Hamsters from Multiple Clostridioides difficile Strains
Jacqueline R. Phan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile
Deirdre A. Collins et al.
LETTERS IN APPLIED MICROBIOLOGY (2022)
Multi-omics investigation of Clostridioides difficile-colonized patients reveals pathogen and commensal correlates of C. difficile pathogenesis
Skye R. S. Fishbein et al.
ELIFE (2022)
Basis of narrow-spectrum activity of fidaxomicin on Clostridioides difficile
Xinyun Cao et al.
NATURE (2022)
The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin
Tetsuo Yamaguchi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2020)
Recurrent Clostridioides difficile infection: Recognition, management, prevention
Constantine Tsigrelis
CLEVELAND CLINIC JOURNAL OF MEDICINE (2020)
Measuring the Antimicrobial Activity of Lauric Acid against Various Bacteria in Human Gut Microbiota Using a New Method
Miki Matsue et al.
CELL TRANSPLANTATION (2019)
Effect of the Synthetic Bile Salt Analog CamSA on the Hamster Model of Clostridium difficile Infection
Amber Howerton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Lauric Acid Is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model
Hsiao-Ting Yang et al.
FRONTIERS IN MICROBIOLOGY (2018)
Novel Antimicrobials for the Treatment of Clostridium difficile infection
Nicola Petrosillo et al.
FRONTIERS IN MEDICINE (2018)
Antibiotic Resistance and Toxin Production of Clostridium difficile Isolates from the Hospitalized Patients in a Large Hospital in Florida
Zhong Peng et al.
FRONTIERS IN MICROBIOLOGY (2017)
Recurrent Clostridium difficile infection and the microbiome
Rowena Almeida et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Breakthroughs in the treatment and prevention of Clostridium difficile infection
Larry K. Kociolek et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents
Angie M. Jarrad et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile
Matthew Miezeiewski et al.
ISME JOURNAL (2015)
The Properties of Lauric Acid and Their Significance in Coconut Oil
Fabian M. Dayrit
JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY (2015)
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Charlie G. Buffie et al.
NATURE (2015)
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Jasmohan S. Bajaj et al.
JOURNAL OF HEPATOLOGY (2014)
Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance
Kathleen Mullane
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2014)
Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea
Vijay C. Antharam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
UPARSE: highly accurate OTU sequences from microbial amplicon reads
Robert C. Edgar
NATURE METHODS (2013)
Variations in Virulence and Molecular Biology among Emerging Strains of Clostridium difficile
Jonathan J. Hunt et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2013)
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Christian Quast et al.
NUCLEIC ACIDS RESEARCH (2013)
Amixicile, a Novel Inhibitor of Pyruvate:Ferredoxin Oxidoreductase, Shows Efficacy against Clostridium difficile in a Mouse Infection Model
Cirle A. Warren et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
Oliver A. Comely et al.
CLINICAL INFECTIOUS DISEASES (2012)
Suppression of Clostridium difficile in the Gastrointestinal Tracts of Germfree Mice Inoculated with a Murine Isolate from the Family Lachnospiraceae
Angela E. Reeves et al.
INFECTION AND IMMUNITY (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection
Ellie J. C. Goldstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Synthesis and Antimicrobial Evaluation of Nitazoxanide-Based Analogues: Identification of Selective and Broad Spectrum Activity
T. Eric Ballard et al.
CHEMMEDCHEM (2011)
Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291
Anthony M. Buckley et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Clostridium difficile infection: epidemiology, risk factors and management
Ashwin N. Ananthakrishnan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon
Mary C. Rea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection
Angela E. Reeves et al.
GUT MICROBES (2011)
Biological activity of modified and exchanged 2-amino-5-nitrothiazole amide analogues of nitazoxanide
T. Eric Ballard et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Murine Model of Clostridium difficile Infection with Aged Gnotobiotic C57BL/6 Mice and a BI/NAP1 Strain
S. W. Pawlowski et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Dissecting interactions between nucleosides and germination receptors in Bacillus cereus 569 spores
Tetyana Dodatko et al.
MICROBIOLOGY-SGM (2010)
Study of the In Vitro Activities of Rifaximin and Comparator Agents against 536 Anaerobic Intestinal Bacteria from the Perspective of Potential Utility in Pathology Involving Bowel Flora
S. M. Finegold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A Mouse Model of Clostridium difficile-Associated Disease
Xinhua Chen et al.
GASTROENTEROLOGY (2008)
Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni
Paul S. Hoffman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Emergence of Clostridium difficile-associated disease in North America and Europe
E. J. Kuijper et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species
GA Pankuch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Nitazoxanide: A new thiazolide antiparasitic agent
LM Fox et al.
CLINICAL INFECTIOUS DISEASES (2005)
The role of pyruvate ferredoxin oxidoreductase in pyruvate synthesis during autotrophic growth by the Wood-Ljungdahl pathway
C Furdui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
